(Q36950813)

English

Discordance between serum cardiac biomarker and immunoglobulin-free light-chain response in patients with immunoglobulin light-chain amyloidosis treated with immune modulatory drugs

scientific article published on October 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Discordance between serum cardiac biomarker and immunoglobulin-free light-chain response in patients with immunoglobulin light-chain amyloidosis treated with immune modulatory drugs (English)

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

0 references

1 reference

based on heuristic

inferred from title

2

object named as

David Dingli

1 reference

Europe PubMed Central

17 August 2017

PMC publication ID

Angela Dispenzieri

1

object named as

Angela Dispenzieri

1 reference

Europe PubMed Central

17 August 2017

PMC publication ID

13

object named as

Robert A Kyle

1 reference

Europe PubMed Central

17 August 2017

PMC publication ID

5

object named as

Martha Q Lacy

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Stephen J. Russell

12

object named as

Stephen J Russell

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

S. Vincent Rajkumar

4

object named as

S Vincent Rajkumar

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

14

object named as

Morie A Gertz

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Suzanne R Hayman

6

object named as

Suzanne Hayman

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

11

object named as

John A Lust

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

3

object named as

Shaji K Kumar

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Kristen E Detweiler Short

10

object named as

Kristen Detweiler-Short

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Stephen R Zeldenrust

8

object named as

Stephen Zeldenrust

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

7

object named as

Frances Buadi

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

author name string

Nelson Leung

9

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

publication date

1 October 2010

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

American Journal of Hematology

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

85

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

10

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

757-759

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

A phase II trial of cyclophosphamide, lenalidomide and dexamethasone in previously treated patients with AL amyloidosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691013

9 September 2017

The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691013

9 September 2017

Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691013

9 September 2017

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691013

9 September 2017

Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691013

9 September 2017

Poor tolerance to high doses of thalidomide in patients with primary systemic amyloidosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691013

9 September 2017

Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691013

4 September 2018

Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3691013

4 September 2018

Identifiers

10.1002/AJH.21822

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36950813&oldid=1739060079"